Clinical Trials in Baltimore

Showing 11861-11880 of 20,142 trials

Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies

NCT01110226

This is a Phase I Clinical Trial. Phase I studies are designed to determine the amount of investigational drugs that can be safely tolerated and to define the side effects that limit the dose. The drug administered in this study is KML-001. It is a highly soluble, orally available arsenic agent. It is currently being tested to determine its effects on telomerase activity. In other words, the purpose of this research study is to find the highest dose of KML001, that can be given without causing severe side effects when it is combined with a standard, commercially available anti-cancer drug called cisplatin.

Non-Small Cell Lung Cancer, Small Cell Lung CancerPlatinum Responsive Malignancies

University of Maryland, Baltimore23 participantsStarted Apr 2010

Baltimore, Maryland, United States

COMPLETEDPhase 2< 1 mile

Peanut Oral Immunotherapy in Children

NCT01867671

This is a randomized, double-blind, placebo-controlled, multi-center study comparing peanut oral immunotherapy (OIT) to placebo in the induction of tolerance and desensitization in peanut-allergic children. Eligible participants with peanut allergy will be randomly assigned to receive either peanut OIT or placebo for 134 weeks followed by peanut avoidance for 26 weeks.

Peanut Hypersensitivity

National Institute of Allergy and Infectious Diseases (NIAID)146 participantsStarted Aug 2013

Little Rock, Arkansas, United States • Stanford, California, United States • Baltimore, Maryland, United States +2 more locations

Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies

Peanut Oral Immunotherapy in Children

Find Trials by Condition in Baltimore

Screening Protocol to Evaluate Volunteers for NIA Approved Studies

Genetic Analysis of Hereditary Prostate Cancer

EMPower: Electronic Media Powering Positive Health Changes in Youth

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Glutamine Supplementation in People With Immune Dysregulation

Family Myopia Study

Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma

Novel Endoluminal Clinical TreAtment of Reflux

Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event